Huapont Life Sciences Co Ltd (002004) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Huapont Life Sciences Co Ltd (002004) has a cash flow conversion efficiency ratio of 0.039x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥635.17 Million ≈ $92.95 Million USD) by net assets (CN¥16.10 Billion ≈ $2.36 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Huapont Life Sciences Co Ltd for the company's overall valuation and market capitalisation.
Huapont Life Sciences Co Ltd - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Huapont Life Sciences Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Huapont Life Sciences Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Huapont Life Sciences Co Ltd ranked by their cash flow conversion efficiency. Explore 002004 operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.
SHG:605016
|
0.022x |
|
Rizhao Port Co Ltd
SHG:600017
|
0.017x |
|
Nuvoco Vistas Corporation Limited
NSE:NUVOCO
|
0.057x |
|
Wam Leaders Ltd
AU:WLE
|
0.048x |
|
Shenzhen Xunjiexing Technology Corp. Ltd.
SHG:688655
|
-0.007x |
|
Camel Group Co Ltd
SHG:601311
|
0.017x |
|
Jiangling Motors Corp Ltd
SHE:000550
|
0.015x |
|
Nexwise Intelligence China Limited
SHE:301248
|
N/A |
Annual Cash Flow Conversion Efficiency for Huapont Life Sciences Co Ltd (2002–2025)
The table below shows the annual cash flow conversion efficiency of Huapont Life Sciences Co Ltd from 2002 to 2025. View Huapont Life Sciences Co Ltd share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥16.98 Billion ≈ $2.48 Billion |
CN¥2.10 Billion ≈ $306.72 Million |
0.123x | +17.53% |
| 2024-12-31 | CN¥15.47 Billion ≈ $2.26 Billion |
CN¥1.63 Billion ≈ $237.83 Million |
0.105x | +9.60% |
| 2023-12-31 | CN¥16.58 Billion ≈ $2.43 Billion |
CN¥1.59 Billion ≈ $232.59 Million |
0.096x | -34.12% |
| 2022-12-31 | CN¥16.55 Billion ≈ $2.42 Billion |
CN¥2.41 Billion ≈ $352.34 Million |
0.145x | +81.32% |
| 2021-12-31 | CN¥15.82 Billion ≈ $2.32 Billion |
CN¥1.27 Billion ≈ $185.79 Million |
0.080x | -52.20% |
| 2020-12-31 | CN¥14.14 Billion ≈ $2.07 Billion |
CN¥2.37 Billion ≈ $347.20 Million |
0.168x | +6.76% |
| 2019-12-31 | CN¥13.24 Billion ≈ $1.94 Billion |
CN¥2.08 Billion ≈ $304.68 Million |
0.157x | +5.02% |
| 2018-12-31 | CN¥12.75 Billion ≈ $1.87 Billion |
CN¥1.91 Billion ≈ $279.29 Million |
0.150x | +236.59% |
| 2017-12-31 | CN¥13.30 Billion ≈ $1.95 Billion |
CN¥591.40 Million ≈ $86.54 Million |
0.044x | -6.99% |
| 2016-12-31 | CN¥10.70 Billion ≈ $1.57 Billion |
CN¥511.90 Million ≈ $74.91 Million |
0.048x | +45.38% |
| 2015-12-31 | CN¥10.41 Billion ≈ $1.52 Billion |
CN¥342.45 Million ≈ $50.11 Million |
0.033x | -58.65% |
| 2014-12-31 | CN¥5.73 Billion ≈ $838.76 Million |
CN¥455.96 Million ≈ $66.72 Million |
0.080x | -8.68% |
| 2013-12-31 | CN¥4.01 Billion ≈ $587.13 Million |
CN¥349.51 Million ≈ $51.14 Million |
0.087x | -0.07% |
| 2012-12-31 | CN¥2.96 Billion ≈ $432.69 Million |
CN¥257.75 Million ≈ $37.72 Million |
0.087x | +66.69% |
| 2011-12-31 | CN¥2.59 Billion ≈ $378.40 Million |
CN¥135.23 Million ≈ $19.79 Million |
0.052x | -32.16% |
| 2010-12-31 | CN¥1.04 Billion ≈ $151.57 Million |
CN¥79.84 Million ≈ $11.68 Million |
0.077x | -44.01% |
| 2009-12-31 | CN¥897.32 Million ≈ $131.31 Million |
CN¥123.53 Million ≈ $18.08 Million |
0.138x | -1.49% |
| 2008-12-31 | CN¥814.07 Million ≈ $119.12 Million |
CN¥113.76 Million ≈ $16.65 Million |
0.140x | +28.94% |
| 2007-12-31 | CN¥730.86 Million ≈ $106.95 Million |
CN¥79.21 Million ≈ $11.59 Million |
0.108x | -14.27% |
| 2006-12-31 | CN¥522.90 Million ≈ $76.52 Million |
CN¥66.10 Million ≈ $9.67 Million |
0.126x | +27.50% |
| 2005-12-31 | CN¥440.68 Million ≈ $64.49 Million |
CN¥43.69 Million ≈ $6.39 Million |
0.099x | -43.60% |
| 2004-12-31 | CN¥401.64 Million ≈ $58.77 Million |
CN¥70.60 Million ≈ $10.33 Million |
0.176x | -54.80% |
| 2003-12-31 | CN¥145.74 Million ≈ $21.33 Million |
CN¥56.68 Million ≈ $8.29 Million |
0.389x | +7.74% |
| 2002-12-31 | CN¥102.18 Million ≈ $14.95 Million |
CN¥36.88 Million ≈ $5.40 Million |
0.361x | -- |
About Huapont Life Sciences Co Ltd
Huapont Life Sciences Co.,Ltd. engages in the medicine, medical care, agrochemicals, new materials, tourism, and other businesses in China and internationally. It is involved in the production and sale of pharmaceutical preparations and raw materials. The company also offers medicines for skin, tuberculosis, anti-infection, respiratory, anti-tumor, and cardiovascular, as well as health management… Read more